A promising bioelectronics target in our neck
A promising bioelectronics target in our neck Read More »
HAPPY EASTER FROM THE CORTEC TEAM!
Even with our heads down in innovation, we can’t help but feel the Easter spirit starting to bloom. We prepared some egg-citing recent highlights in implantable electrode technology for you. Enjoy this Easter Basket full of Stories and News! To our valued customers, partners, and friends, we wish you a Happy Easter!
HAPPY EASTER FROM THE CORTEC TEAM! Read More »
CorTec Receives FDA Breakthrough Device Designation for Its Brain Interchange System in Stroke Rehabilitation — the First BCI Worldwide Designated for Stroke Motor Rehabilitation
Freiburg, Germany, April 08, 2026 — CorTec GmbH, a pioneer in fully implantable brain-computer interfaces (BCI), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company’s Brain Interchange™ system. The designation covers the use of direct cortical electrical stimulation to support motor recovery in people living with
A Breakthrough after a Stroke
The University of Washington shared the inspiring story of a stroke patient who regained movement thanks to a pioneering brain implant technology developed by CorTec. After two strokes, Matt Kidd’s left side was almost completely paralyzed. Years of therapy brought little progress, until he became part of a clinical trial at the University of
A Breakthrough after a Stroke Read More »
Bernstein-CorTec-Award 2025: Call for Nominations is open
CorTec and the Bernstein Center Freiburg are pleased to announce the Bernstein-CorTec-Award 2025. The award recognizes outstanding scientific achievements in the interdisciplinary field of computational neuroscience and neurotechnology and will be awarded this year for a master’s thesis. Promoting young talent Since its introduction in 2020, the Bernstein-CorTec-Award has honored alternating Master’s and doctoral theses
Bernstein-CorTec-Award 2025: Call for Nominations is open Read More »
CorTec Welcomes Dr. Frank Desiere as Chief Executive Officer
A Strengthened Leadership Team to Accelerate Growth and Innovation CorTec GmbH, a pioneer in active implantable technologies and Brain-Computer Interface (BCI) systems, is pleased to announce the appointment of Dr. Frank Desiere as its new Chief Executive Officer (CEO). This significant leadership milestone highlights CorTec’s commitment to driving innovation and growth in the rapidly
CorTec Welcomes Dr. Frank Desiere as Chief Executive Officer Read More »
Marking a New Era in Medical Device Development – CorTec Announces Strategic Partnership with US-based Heraeus Medevio
CorTec GmbH, a leader in innovative implantable technologies, is pleased to announce a strategic partnership with Heraeus Medevio, based in Minneapolis, USA. This collaboration aims to support customers in the neuromodulation sector, from concept and small series production (CorTec) to large series production (Medevio). Together, the companies will deliver next-generation medical devices and drive innovation
HAPPY EASTER FROM THE CORTEC TEAM!
Easter is just around the corner. Before the CorTec team disappears into a long Easter weekend and the Easter Bunny takes over our cleanroom completely, we prepared some egg-citing recent highlights for you. The Brain Interchange System for Stroke Rehabilitation We are again featured in the latest edition of Open Access Government – more
HAPPY EASTER FROM THE CORTEC TEAM! Read More »
Save the Date – Bernstein Special Seminar on 28th of February
We are happy to invite you to the upcoming Bernstein Special Seminar, taking place in Bernstein Center Freiburg on 28th of February 2024 at 12:15. The prize is awarded annually, alternating for Doctoral and Master theses. In 2023, the prize is awarded to Aadhar Sharma for his Master Thesis on the topic: “The Dynamics of
Save the Date – Bernstein Special Seminar on 28th of February Read More »